NSRX – nasus pharma ltd. ordinary shares (US:NASDAQ)

News

Nasus Pharma to Participate in Upcoming Investor Conferences
Nasus Pharma to Present Data Highlighting Superior Nasal Deposition and Stability of Intranasal Epinephrine Powder at AAAAI 2026
Nasus Pharma Announces Closing of $15.0 Million Private Placement
Nasus Pharma Announces Pricing of $15.0 Million Private Placement
Nasus Pharma Announces Positive Interim Results from Phase 2 Clinical Study of NS002 Intranasal Epinephrine Powder
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com